1,721,078 research outputs found

    Tricyclic antidepressants inhibit Candida albicans growth and biofilm formation

    Full text link
    Candida albicans is a commensal yeast of the human body, able to form biofilms on solid surfaces such as implanted medical devices, and contributes to nosocomial infections. Biofilms have the capacity to resist higher levels of antifungals compared with planktonic cells, and can develop tolerance to commonly used treatments. The necessity to overcome acquired drug resistance and identify new active molecules with low toxicity is a significant problem. It has been reported that some antidepressants have antibacterial properties, but little is known regarding the effect of these drugs on fungi. This study demonstrated the capacity of three tricyclic antidepressants (doxepin, imipramine and nortriptyline) to inhibit the growth and biofilm formation of Candida spp. The antimicrobial potential of the drugs was assessed by studying gene expression, hyphae formation, biofilm growth and maturation. Their negative impact on the growth of C. albicans and other Candida spp. is shown in vitro and with the hepatic S9 system, which is preliminary to any in-vivo test. This study found that the antidepressants considered can inhibit not only hyphae and biofilm formation, but also kill cells in a mature biofilm. Moreover, cell lysis by nortriptyline was observed, along with its synergistic activity with amphotericin B. These findings suggest that tricyclic antidepressants, particularly nortriptyline, should be studied further in drug repositioning programmes to assess their antimycotic capacity in full

    Antimicrobial Properties of Antidepressants and Antipsychotics—Possibilities and Implications

    No full text
    The spreading of antibiotic resistance is responsible annually for over 700,000 deaths worldwide, and the prevision is that this number will increase exponentially. The identification of new antimicrobial treatments is a challenge that requires scientists all over the world to collaborate. Developing new drugs is an extremely long and costly process, but it could be paralleled by drug repositioning. The latter aims at identifying new clinical targets of an “old” drug that has already been tested, approved, and even marketed. This approach is very intriguing as it could reduce costs and speed up approval timelines, since data from preclinical studies and on pharmacokinetics, pharmacodynamics, and toxicity are already available. Antidepressants and antipsychotics have been described to inhibit planktonic and sessile growth of different yeasts and bacteria. The main findings in the field are discussed in this critical review, along with the description of the possible microbial targets of these molecules. Considering their antimicrobial activity, the manuscript highlights important implications that the administration of antidepressants and antipsychotics may have on the gut microbiome

    Known antimicrobials versus nortriptyline in Candida albicans: Repositioning an old drug for new targets

    No full text
    Candida albicans has the capacity to develop resistance to commonly used antimicrobials, and to solve this problem, drug repositioning and new drug combinations are being studied. Nortriptyline, a tricyclic antidepressant, was shown to have the capacity to inhibit biofilm and hyphae formation, along with the ability to efficiently kill cells in a mature biofilm. To use nortriptyline as a new antimicrobial, or in combination with known drugs to increase their actions, it is important to characterize in more detail the effects of this drug on the target species. In this study, the Candida albicans GRACETM collection and a Haplo insufficiency profiling were employed to identify the potential targets of nortriptyline, and to classify, in a parallel screening with amphotericin B, caspofungin, and fluconazole, general multi-drug resistance genes. The results identified mutants that, during biofilm formation and upon treatment of a mature biofilm, are sensitive or tolerant to nortriptyline, or to general drug treatments. Gene ontology analysis recognized the categories of ribosome biogenesis and spliceosome as enriched upon treatment with the tricyclic antidepressant, while mutants in oxidative stress response and general stress response were commonly retrieved upon treatment with any other drug. The data presented suggest that nortriptyline can be considered a “new” antimicrobial drug with large potential for application to in vivo infection models

    Treating dairy parlor wastewater using subsurface-flow constructed wetlands

    No full text
    Two horizontal subsurface flow reed beds to treat parlor effluent as well as domestic sewage, each 75 m(2), were built in 1999. The goal of the project is to verify the efficiency of this treatment system to reduce the polluting load of parlor effluent, which are more polluted than domestic sewage. Throughout the first year of the trial the two wetlands operated one after the other in succession and wastewater inflows and outflows were sampled 20 times. Analyses were made for pH, TSS, COD, BOD5, TKN, NH4-N, NO3-N, P, Cu and Zn. The reduction of suspended solids and organic load remained consistently at levels greater than 90%; those of the nutrients N and P were over 40% and 50%, respectively. The monitoring of the heavy metals Cu and Zn made it possible to verify that their load was reduced consequent to deposit in the sediments in moving through the system, while the phenomenon of assimilation by the reeds was shown to be insignificant. Mycorrhizae were found in the roots of the reeds of both wetlands, which indicates a possible strengthening of the assimilation activity of the plants
    corecore